MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the already approved targeted drug cetuximab (Erbitux) significantly improvedContinue Reading

MONDAY, April 3, 2023 (American Heart Association News) — Brain cells have a complex relationship with the blood vessels around them that can greatly affect the vessels’ ability to function, according to a new science report from the American Heart Association. The scientific statement, published Monday in the AHA journalContinue Reading

MONDAY, April 3, 2023 (HealthDay News) – Pope Francis was back delivering Mass on Palm Sunday, just one day after he was released from the hospital following a three-day stay for bronchitis. Francis, 86, celebrated in St. Peter’s Square in Rome as about 60,000 people looked on, carrying palm frondsContinue Reading

MONDAY, April 3, 2023 (HealthDay News) – After six weeks of in-patient treatment at Walter Reed National MIlitary Medical Center, Sen. John Fetterman is back home in western Pennsylvania and in remission from depression. Fetterman will return to the Senate when Congress reconvenes April 17 after a recess. The PennsylvaniaContinue Reading